These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5832)

  • 1. [Effect of a new beta-sympatholytic agent for ICI 66 082 on hemodynamics and cardiac contraction without and with experimental coronary occlusion].
    Stephan K; Bischoff KO; Geigenmüller L; Diesch J; Meesmann W
    Verh Dtsch Ges Inn Med; 1975; 81():1637-41. PubMed ID: 5832
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
    Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
    Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a new beta-blocking drug (SP/1601) on the extension of experimental acute infarct in anesthetized dogs].
    Merlo L; Brusoni B; Marchetti G
    Boll Soc Ital Cardiol; 1977; 22(7):1048-52. PubMed ID: 36114
    [No Abstract]   [Full Text] [Related]  

  • 4. Atenolol, regional myocardial blood flow and S-T segment in canine ischaemic myocardium [proceedingins].
    Berdeaux A; Boissier JR; Giudicelli JF
    Br J Pharmacol; 1976 Nov; 58(3):411P. PubMed ID: 11019
    [No Abstract]   [Full Text] [Related]  

  • 5. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dose-related effect of the beta sympatholytic agent prindolol (Visken) on hemodynamics and contractility of the heart following experimental coronary occlusion].
    Hübner H; Stephan K; Meesmann W
    Verh Dtsch Ges Inn Med; 1975; 81():317-20. PubMed ID: 1229528
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.
    Pouleur H; Rousseau MF; Mengeot P; Veriter C; Vincent MF; Brasseur LA
    Eur Heart J; 1982 Dec; 3 Suppl D():123-7. PubMed ID: 6130945
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a new beta blockader (SD/1601) on positive levelling of the ST epicardial tracing during coronary occlusion in the narcotized dog].
    Merlo L; Brusoni B; Minoia G; Marchetti G
    Boll Soc Ital Biol Sper; 1977 Mar; 53(6):440-4. PubMed ID: 20906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Smoking and beta adrenergic receptor blockade].
    Carlsen JE; Svendsen TL; Christensen NJ; Trap-Jensen J
    Ugeskr Laeger; 1980 Feb; 142(8):504-8. PubMed ID: 6102813
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: The hypoglycaemic action of ICI 66082 (4-(2-hydroxy-3-isopropyl-aminopropoxy) phenyl acetamide) in the rat.
    Furman BL; Tayo FM
    Br J Pharmacol; 1974 Sep; 52(1):143P. PubMed ID: 4155984
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
    Iliodromitis EK; Tasouli A; Andreadou I; Bofilis E; Zoga A; Cokkinos P; Kremastinos DT
    Eur J Pharmacol; 2004 Sep; 499(1-2):163-9. PubMed ID: 15363963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleviation of myocardial dysfunction and abnormal lactate metabolism during coronary stenosis in dogs by ICI 118,551.
    Noguchi K; Ojiri Y; Nagamine F; Matsuzaki T; Sakanashi M
    Eur J Pharmacol; 1989 Sep; 168(3):315-28. PubMed ID: 2583239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol--pharmacological profile of an unconventional beta-blocker.
    Wolf PS; Smith RD; Khandwala A; Van Inwegen RG; Gordon RJ; Mann WS; Romano DV; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 40():5-11. PubMed ID: 2864065
    [No Abstract]   [Full Text] [Related]  

  • 14. First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs.
    Lange R; Kloner RA; Braunwald E
    Am J Cardiol; 1983 Jun; 51(10):1759-67. PubMed ID: 6134464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of nitroglycerin and of the combination of nitroglycerin and beta inhibitors on systemic and coronary hemodynamics and on cardiac metabolism].
    Marchetti GV; Merlo L; Brusoni B
    Boll Soc Ital Cardiol; 1975; 20(10):1197-205. PubMed ID: 10931
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of cardiac performance in the hypertensive patient. Effect of a beta-blocking agent: atenolol].
    Lehner JP; Simon A; Kehder A; Weiss Y; Tzincoca C; Safar M
    Arch Mal Coeur Vaiss; 1978 Oct; 71(10):1107-12. PubMed ID: 104684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of blockaders of cardiac beta-adrenergic structures on the central hemodynamics and contractile function of the myocardium in acute experimental coronary insufficiency].
    Ol'binskaia LI; Sandrikov VA; Ptashnikova TN; Sadovnikov VI; Trekova NA
    Kardiologiia; 1979 Sep; 19(9):100-3. PubMed ID: 40059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of blockade of adrenergic beta receptors on the development of disorders of cardio- and hemodynamics in shock of immunologic origin].
    Sagach VF; Buriakov IE
    Patol Fiziol Eksp Ter; 1986; (6):32-4. PubMed ID: 2881243
    [No Abstract]   [Full Text] [Related]  

  • 20. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.